Press release
Acute Vulvovaginal Candidiasis Market Exclusive Report on the Latest Revenue and Future Scope
According to the latest research by InsightAce Analytic, the global Acute Vulvovaginal Candidiasis market will be valued at US$ 320.77 Million in 2021. It is expected to reach US$ 485.54 Million by 2030, with a CAGR of 4.8% during a forecast period of 2022-2030.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/1232
The development of numerous treatments and medications to treat this infection is part of the acute vulvovaginal candidiasis market. A yeast infection known as acute vulvovaginal candidiasis (VVC) or vaginal thrush is brought on by the candida Albicans fungal group. Overgrowth of fungus, which results in symptoms including abnormal vaginal discharge, excruciating discomfort during sexual activity, and vaginal itching, causes the infection. The VVC affects approximately 75% of women throughout their lifespans. Although most VVC instances are moderate, some women get severe conditions that result in edema, vaginal wall fissures, and redness.
The population's rising prevalence of acute vulvovaginal candidiasis will likely fuel global market growth over the predicted period. Accelerated R&D on VVC medicines and therapies will probably drive the worldwide acute vulvovaginal candidiasis market during the forecast period. There is a rush among market competitors to submit new drug applications (NDA) to regulatory authorities that will grant them approval to manufacture their products. This aspect is projected to drive the worldwide acute vulvovaginal candidiasis market forward. Over the projected period, the increasing number of patients with vaginal yeast infections is expected to pave the way for growth in the worldwide acute vulvovaginal candidiasis market. During the projected period, the prevalence of the COVID-19 epidemic is expected to hinder growth in the worldwide acute vulvovaginal candidiasis market.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1232
North America is anticipated to be the major contributor to the Acute Vulvovaginal Candidiasis market over the forecast years because of the rising occurrence of acute vulvovaginal candidiasis therapy in this area. In terms of revenue, the United States dominates North America's acute vulvovaginal candidiasis market. In addition, the Asia Pacific regional market is expected to register significant growth during the estimated period. Rising awareness of this illness among rural women and initiatives such as the Indian government's 'Swachhta, Swasthya, and Suvidha' for the cleanliness of disadvantaged women are driving factors for the growth of the global acute vulvovaginal candidiasis market in this area.
Major market players operating in the Acute Vulvovaginal Candidiasis market include
Mycovia Pharmaceuticals, Inc., Scynexis, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Padagis LLC, ProFem GmbH, Amplyx Pharmaceuticals Inc., MethylGene Inc., Ferrer Internacional S.A., Pfizer, Inc., and Other Prominent Players.
Recent collaborations and agreements in the market:
• In February 2021, Scynexis, a biotech business, announced an agreement with Amplity Health, a pharmaceutical company, to extend their support for the commercialization of BrexafemmeTM, a brand name of Ibrexafungerp for vaginal infections, in the United States.
• In October 2019, Mycovia Pharmaceuticals, an American pharmaceutical business, announced a collaboration with Gedeon Richter, a Hungarian pharmaceutical company, to manufacture VT-1161 for the treatment of vulvovaginal candidiasis.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1232
Market Segments
Global Acute Vulvovaginal Candidiasis Market, by Drug Type, 2022-2030 (Value US$ Mn)
• Clotrimazole
• Nystatin
• Fluconazole
• Terbinafine
• Terconazole
• Other Drug Types
Global Acute Vulvovaginal Candidiasis Market, by Route of Administration, 2022-2030 (Value US$ Mn)
• Oral
• Intravenous
• Topical
Global Acute Vulvovaginal Candidiasis Market, by Distribution Channel, 2022-2030 (Value US$ Mn)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Acute Vulvovaginal Candidiasis Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Acute Vulvovaginal Candidiasis market
To receive an industry overview and future trends of the Acute Vulvovaginal Candidiasis market
To analyze the Acute Vulvovaginal Candidiasis market drivers and challenges
To get information on the Acute Vulvovaginal Candidiasis market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Acute Vulvovaginal Candidiasis market industry
Get More Information @
https://www.insightaceanalytic.com/report/-acute-vulvovaginal-candidiasis-market-/1232
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Vulvovaginal Candidiasis Market Exclusive Report on the Latest Revenue and Future Scope here
News-ID: 3811832 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…
